Hep C Cost-Effectiveness Study Supports Limiting Incivek Use
This article was originally published in The Pink Sheet Daily
Executive Summary
Study presented at AASLD provides evidence of the potential value of genotyping patients prior to treatment with new protease inhibitors; Medco ready to start testing program.